Key result
Obesity with altered glucose tolerance was associated with significantly increased ANGPTL-4 levels compared to lean participants, and levels decreased with weight loss over 2 years.
Why the study?
Are circulating ANGPTL-4 levels associated with obesity and altered glucose tolerance, and do they change with weight loss?
Observational (n=333)
Are circulating ANGPTL-4 levels associated with obesity and altered glucose tolerance, and do they change with weight loss?
Circulating ANGPTL-4 levels are elevated in obesity with altered glucose tolerance and track with long-term body weight changes, suggesting a role in metabolic regulation.
Answers are grounded in this paper and cite their sources.
ANGPTL-4 may mark metabolic dysfunction in obesity; observational data leave open causal role and clinical utility.
SCOPE: Angiopoietin-like protein 4 (ANGPTL-4) regulates plasma lipoprotein levels, but its relevance in human obesity and type 2 diabetes (T2D) is largely unknown. We aim to investigate the regulation of circulating ANGPTL-4 levels in obesity, T2D, and after changes in body weight. METHODS AND RESULTS: Circulating ANGPTL-4 levels were measured in two different cohorts. First, in a cross-sectional study, we evaluated ANGPTL-4 levels in lean and obese patients with normoglycemia or with altered glucose tolerance (AGT; n = 282). Second, in a longitudinal intervention study, 51 obese participants were evaluated. A hypocaloric diet was prescribed, with follow-up 2 years later. ANGPTL-4 levels were significantly increased in obese patients with AGT compared to lean participants. Moreover, ANGPTL-4 was positively correlated with BMI, waist circumference, fat mass, HbA1c, HOMA-IR, fasting triglycerides, and with inflammatory markers. Participants gaining weight after the follow-up showed increased ANGPTL-4 levels in parallel to increased BMI, fat mass, and fasting glucose, while ANGPTL-4 levels were reduced in participants losing weight. CONCLUSION: Our data support a relevant role of ANGPTL-4 in human obesity and its involvement in long-term body weight changes.
No takes yet. Share an insight, caveat, or question.
Barja-Fernández et al. (2018) conducted an observational in Obesity and altered glucose tolerance (n=333). Obesity, altered glucose tolerance, and weight change vs. Lean participants and weight loss was evaluated on Circulating ANGPTL-4 levels. Obesity with altered glucose tolerance was associated with significantly increased ANGPTL-4 levels compared to lean participants, and levels decreased with weight loss over 2 years.
Synapse has enriched 10 related papers. Consider them for comparative context: